Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Conditional Mutation of SMC5 in Mouse Embryonic Fibroblasts.

Gaddipati H, Pryzhkova MV, Jordan PW.

Methods Mol Biol. 2019;2004:35-46. doi: 10.1007/978-1-4939-9520-2_4.

2.

Conditional mutation of Smc5 in mouse embryonic stem cells perturbs condensin localization and mitotic progression.

Pryzhkova MV, Jordan PW.

J Cell Sci. 2016 Apr 15;129(8):1619-34. doi: 10.1242/jcs.179036. Epub 2016 Feb 26.

3.

Carbon nanotube-based substrates for modulation of human pluripotent stem cell fate.

Pryzhkova MV, Aria I, Cheng Q, Harris GM, Zan X, Gharib M, Jabbarzadeh E.

Biomaterials. 2014 Jun;35(19):5098-109. doi: 10.1016/j.biomaterials.2014.03.011. Epub 2014 Mar 29.

4.

Patterning Pluripotent Stem Cells at a Single Cell Level.

Pryzhkova MV, Harris GM, Ma S, Jabbarzadeh E.

J Biomater Tissue Eng. 2013 Aug;3(4):461-471. doi: 10.1166/jbt.2013.1106. Epub 2013 Aug 1.

5.

Concise review: carbon nanotechnology: perspectives in stem cell research.

Pryzhkova MV.

Stem Cells Transl Med. 2013 May;2(5):376-83. doi: 10.5966/sctm.2012-0151. Epub 2013 Apr 9. Review.

6.

Stem cells: will they ever be the same?

Pryzhkova MV.

Regen Med. 2013 Mar;8(2):97-9. doi: 10.2217/rme.13.9. No abstract available.

PMID:
23477389
7.

Challenges and strategies for generating therapeutic patient-specific hemangioblasts and hematopoietic stem cells from human pluripotent stem cells.

Peters A, Burridge PW, Pryzhkova MV, Levine MA, Park TS, Roxbury C, Yuan X, PĂ©ault B, Zambidis ET.

Int J Dev Biol. 2010;54(6-7):965-90. doi: 10.1387/ijdb.093043ap. Review.

8.

Erythropoietic differentiation of a human embryonic stem cell line harbouring the sickle cell anaemia mutation.

Pryzhkova MV, Peters A, Zambidis ET.

Reprod Biomed Online. 2010 Aug;21(2):196-205. doi: 10.1016/j.rbmo.2010.04.017. Epub 2010 Apr 24.

9.

HLA homozygous stem cell lines derived from human parthenogenetic blastocysts.

Revazova ES, Turovets NA, Kochetkova OD, Agapova LS, Sebastian JL, Pryzhkova MV, Smolnikova VI, Kuzmichev LN, Janus JD.

Cloning Stem Cells. 2008 Mar;10(1):11-24.

PMID:
18092905
10.

Patient-specific stem cell lines derived from human parthenogenetic blastocysts.

Revazova ES, Turovets NA, Kochetkova OD, Kindarova LB, Kuzmichev LN, Janus JD, Pryzhkova MV.

Cloning Stem Cells. 2007 Fall;9(3):432-49.

PMID:
17594198
11.

Analysis of expression of genes specific for pluripotent and primordial germ cells in human and mouse embryonic stem cell lines.

Gordeeva OF, Krasnikova NY, Larionova AV, Krylova TA, Polyanskaya GG, Zinov'eva RD, Gulyaev DV, Pryzhkova MV, Nikol'skii NN, Khrushchov NG.

Dokl Biol Sci. 2006 Jan-Feb;406:115-8. No abstract available.

PMID:
16572832
12.

[Transcription and mRNA splicing of the human lactoferrin gene controlled by the regulatory region of the bovine alphaS1 casein gene in the mammary gland of transgenic mice and in mouse embryonic stem cells].

Zakharova ES, Pryzhkova MV, Kibardin AV, Ermolkevich TG, Kadulin SG, Gnuchev NV, Kiselev SL.

Genetika. 2005 Mar;41(3):299-306. Russian.

PMID:
15865283
13.

[Stem cells: current trends of investigations].

Pryzhkova MV, Lagar'kova MA.

Ontogenez. 2004 Nov-Dec;35(6):473-5. Russian. No abstract available.

PMID:
15624781
14.

[Use of genetically modified embryonic stem cells for creating transgenic animals].

Pryzhkova MV, Zakeeva IR, Kibardin AV, Georgiev GP, Kiselev SL.

Genetika. 2004 Mar;40(3):311-5. Russian.

PMID:
15125244

Supplemental Content

Loading ...
Support Center